KYTX Kyverna: Rasio rega marang prakiraan pendapatan

Tandha merek Kyverna Therapeutics, Inc. (KYTX)

The scaling of CAR-T therapy trials is currently creating a positive market backdrop. The forward P/S of Kyverna Therapeutics (KYTX) clearly demonstrates the dynamics of revenue expectations, with the metric currently standing at . The business of Kyverna Therapeutics focuses on replacing drug-based treatment with a one-time cell infusion for lupus. The development of innovative therapy methods also relies on close collaboration with leading academic centers.

KYTX (Kyverna Therapeutics Inc.) riwayat Rasio kapitalisasi pasar marang pendapatan mangsa ngarep saka 04.07.2022 nganti 17.11.2026

KYTX (kyvernatx.com): rincian analitis lan laporan miturut indikator

- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
Ringkesan analisis perusahaan:KYTX (Kyverna Therapeutics)
Sampel barang Kyverna Therapeutics

The resilience of Kyverna Therapeutics (KYTX) market capitalization to volatility depends on the successful implementation of robotic complexes and end-to-end control systems for cell therapy dosing. By analyzing changes in the forward P/S ratio, an investor assesses the relationship between market value and projected revenue, which allows for the identification of an overbought asset and the avoidance of loss asymmetry during a sector correction.

Analisis pesaing Kyverna Therapeutics

Multiplikator Forward P/S ARGX (argenx.com)|BioNTech Group (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ABIVAX - Multiplikator Forward P/S|ADMA - Multiplikator Forward P/S|Protagonist (PTGX) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Immunovant Inc|Rasio rega marang prakiraan pendapatan Kiniksa Pharmaceuticals|Grifols Group (GRFS) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Adaptive Biotechnologies Corp (ADPT)|Rasio rega marang prakiraan pendapatan CLDX (Celldex Therapeutics)|Rasio rega marang prakiraan pendapatan Aurinia Pharma AUPH|Rega forward marang dodolan BCRX|VERA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan DNTH (Dianthus Therapeutics)|Pharvaris N.V. (PHVS) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep AbCellera Biologics (ABCL)|TRML (Tourmaline Bio Inc) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PGEN (Intrexon)|Multiplikator forward rega marang pendapatan PHAR (Pharming)|NKTR (Nektar) - Rega forward marang dodolan|Multiplikator Forward P/S UPB (upstreambio.com)|ZBIO (Zenas Biopharma Inc) - Rega mangsa ngarep marang pendapatan|IMNM - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Gossamer Bio Inc GOSS|KALV: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Septerna Pharma|PVLA (Pieris Corp) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan SVRA|Multiplikator Forward P/S RIGL|Multiplikator forward rega marang pendapatan AnaptysBio Corp ANAB|Astria Therapeutics Inc - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake enGene Holdings Inc. (ENGN)|RAPT Therapeutics Inc. - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aerovate Therapeutics, Inc.|ACRS (Aclaris Therapeutics) - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Tiziana Life Sciences Ltd. (TLSA)|Multiplikator forward rega marang pendapatan CABA|Ventyx Biosciences (VTYX) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S THTX|AVTX (Avalo Therapeutics, Inc) - Rega forward marang dodolan|Multiplikator Forward P/S ELDN (eledon.com)|AGEN - Multiplikator forward rega marang pendapatan|CLYM - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan ZURA|ATYR: Multiplikator Forward P/S|Adagene Corp (ADAG) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan IMA|Shattuck Labs, Inc. - Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Equillium Inc (EQ)|Multiplikator Forward P/S Connect Biopharma Holdings (CNTB)|Rasio rega marang prakiraan pendapatan Immunic, Inc. IMUX|Multiplikator Forward P/S Atara Biotherapeutics ATRA|IFRX - Rasio rega marang prakiraan pendapatan|XFOR: Rasio rega marang prakiraan pendapatan|ACET: Multiplikator Forward P/S|CELU - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan inmunebio.com|Kapitalisasi marang prakiraan pendapatan BRNS (barinthusbio.com)|Multiplikator Forward P/S KZR|Multiplikator Forward P/S SAB Biotherapeutics, Inc (SABS)|Multiplikator Forward P/S AKTX (Akari Therapeutics, Plc)|Multiplikator Forward P/S enlivex.com ENLV|QTTB: Multiplikator forward rega marang pendapatan|GOVX - Multiplikator Forward P/S|Edesa Biotech Inc (EDSA) - Rasio rega marang prakiraan pendapatan|IBIO - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan carismatx.com|XTLB: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan aptevotherapeutics.com APVO|AIM - Multiplikator forward rega marang pendapatan|Aditxt - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake GRI Bio Corporation GRI|xortx.com (XRTX) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep reshapelifesciences.com (HIND)|Rasio rega marang prakiraan pendapatan Revelation Bio|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Indaptus Therapeutics, Inc. INDP|Rasio rega marang prakiraan pendapatan BiondVax Pharmaceuticals (SCNI)|Multiplikator forward rega marang pendapatan CalciMedica CALI|Rasio rega marang prakiraan pendapatan Affimed AFMD|ALLK - Multiplikator forward rega marang pendapatan|HOOKIPA Pharma, Inc. - Multiplikator Forward P/S|Rega forward marang dodolan IGMS (igmbio.com)|ITOS (iTeos Therapeutics, Inc.) - Multiplikator forward rega marang pendapatan|Ocean Biomedical Corp (OCEA) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Multiplikator Forward P/S thirdharmonicbio.com